PREDNIDERM
PREDNIDERM
Authorised
- Prednisolone acetate
- NEOMYCIN SULFATE
Product identification
Medicine name:
PREDNIDERM
Active substance:
- Prednisolone acetate
- NEOMYCIN SULFATE
Target species:
-
Dog
-
Cat
-
Horse
Route of administration:
-
Cutaneous use
Product details
Active substance and strength:
-
Prednisolone acetate1.34/milligram(s)1.00gram(s)
-
NEOMYCIN SULFATE333.33/international unit(s)1.00gram(s)
Pharmaceutical form:
-
Cutaneous emulsion
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QD07CA01
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Luxembourg
Available in:
-
Luxembourg
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Legal basis not covered by Directive 2001/82/EC
Marketing authorisation holder:
- Vetoquinol S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
- Vetoquinol S.A.
Responsible authority:
- Ministry Of Health And Social Security
Authorisation number:
- V 808/09/07/1232
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it
in another language below.
French (PDF)
Published on: 20/03/2024